Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes

Patients with diabetes have a higher incidence of bladder cancer; however, the association between thiazolidinedione use and bladder cancer risk has been controversial. We aimed to investigate whether pioglitazone or rosiglitazone use is associated with bladder cancer risk in patients with type 2 di...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eugene, Jang, Suk-Yong, Kim, Gyuri, Lee, Yong-ho, Choe, Eun Yeong, Nam, Chung Mo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753931/
https://www.ncbi.nlm.nih.gov/pubmed/26871835
http://dx.doi.org/10.1097/MD.0000000000002786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753931/
https://www.ncbi.nlm.nih.gov/pubmed/26871835
http://dx.doi.org/10.1097/MD.0000000000002786

Ejemplares similares